Standardization of Some Marketed Herbal Formulation Used in Diabetes

Authors

  • Manish A. Kamble Kamla Nehru College of Pharmacy, Butibori, Nagpur 441108 (Maharashtra) India.
  • Mayuri R. Mane Kamla Nehru College of Pharmacy, Butibori, Nagpur 441108 (Maharashtra) India
  • Ashwini R. Ingole Kamla Nehru College of Pharmacy, Butibori, Nagpur 441108 (Maharashtra) India.
  • Disha M. Dhabarde Kamla Nehru College of Pharmacy, Butibori, Nagpur 441108 (Maharashtra) India.

Keywords:

Standardization, Antidiabetes formulation, Diabetes mellitus, WHO guidelines

Abstract

Herbal Drugs have been used since ancient times as medicines for the treatment of range of diseases.
The herbal medicine and their preparations have been widely used by the world population in developing
and developed countries owing to its natural origin safety, efficacy lesser side effects or dissatisfaction
with the results of synthetic drugs. They are effective in all types of diabetes including Polyuria, it has
been standardized by modern scientific quality control processes both for the raw material and finished
product obeying to WHO’s guidelines. The evaluation of herbal formulations provides values for different
parameters which will help to put forth new standards to these traditional antidiabetic formulations. These
new standards will help to maintain consistency to various batches. The active constituents from various
parts of plants will effectively increases the potency & efficacy of herbal formulations. These parameters
will help to study pharmacological effect in comparison to modern antidiabetic drugs.

References

1. EMEA. Quality of Herbal Medicinal Products.
Guidelines. European Agency for the Evaluation of
Medicinal Products (EMEA), London, 1998.
2. Anonymous, Quality Control Methods for Medicinal
plants materials.( an authorized publication of W.H.O.
Geneva). New Delhi: A.I.T.B.S. publisher& Distributors;
2002.pp. 11, 18, 61-63.
3. WHO Quality Control Methods for Medicinal Plant
Materials, World Health Organization, Geneva, 1998.
4. 4. Kokate C.K., Gokhale, S.B. 2001. Practical
Pharmacognosy. 2nd ed. Nirali Prakashan, Pune, p.
14-19.
5. Kohei K., Pathophysiology of Type 2 Diabetes and
Its Treatment Policy. JMAJ, January/February 2010
53(1); 41-46.
6. 6. Rendel M., Advanced in Diabetes for the millennium:
Drug therapy of Type 2 diabetes, Med.Gen 2004, 6.
7. Algar R M. et al. Evaluation of standardisation
parameters, pharmacognostic study, preliminary
phytochemical screening and in vitro antidiabetic activity
of Emblica officinalis fruits as per WHO guidelines.
Journal of Pharmacognosy and Phytochemistry 2014;
3(4): 21-28.
8. Bignoia P et. al. Pharmacognostical and physico-chemical
standardization of Syzygium cumini and Azadirachta
indica seed. Asian Pacific Journal of Tropical Biomedicine
2012; 2(1): S290-S295.
9. Ahamad J. et. al., Development and validation of HPTLC
densitometric method for estimation of charantin in
Momordica charantia fruits and herbal formulation.
Journal of Pharmacognosy and Phytochemistry 2014;
2 (5): 172-176.
10. Swapnil G, Patil. Standard Tools For Evaluation Of
Herbal Drugs: An Overview, The Pharma Innovation
Journal. 2013; 2(9):60.
11. Neeraj Choudhary, Bhupinder Singh Sekhon. An
overview of advances in the standardization of herbal
drugs, J Pharm Educ Res 2011; 2(2).

Downloads

Published

2018-09-11